VANCOUVER, March 4, 2013 /CNW/ - Biocell Labs Inc., a wholly owned
subsidiary of Abattis Bioceuticals Corp. (the "Company" or "Abattis")
(OTC PINK: ATTBF) (CNSX: FLU), announces the engagement of Dr. Paula
Brown to provide the Company with the expertise and assistance needed
to expand its capacity into the production of novel bio-pharmaceutical
Mr. Mike Withrow, Chief Executive Officer on behalf of the Company,
stated, "we are very pleased to have Dr. Brown join the Board of
Biocell Labs Inc. with her extensive knowledge, the Company continues
to deliver on its plan to become a fully integrated bioceutical company
that offers cutting-edge proprietary products to the medicinal,
nutraceutical and cosmetic industries."
Paula N. Brown, Ph.D., Director of Applied Research for BCIT's Natural
Health & Food Products Research Group stated, "I am very excited about
this opportunity to work with Biocell Labs Inc. to advance their
integrated model, employing vertical automated growing systems and
novel extraction technologies, to develop health and wellness products
derived from medicinal plants." As far back as 2001 inconsistencies in
raw materials, poor product quality and the absence of validated
analytical methods have been identified as a public health risk and
barrier to rigorous scientific study. Dr. Brown went on to state, "my
research has grown out of a desire to apply scientific principles and
advanced chemoanalytical tools to ensure consumers have confidence in
the products they are ingesting."
Abattis Bioceutical Corporation would also like to announce that it has
acquired from Dr. Brown a portfolio of natural health product formulas
focusing on pain management, immunity & inflammation and cognitive
function in exchange for 400,000 shares of Abattis.
The Biography of Dr. Paula Brown
Dr. Paula Brown, as Director of the BC Institute of Technology's Natural
Health and Food Products Research Group, has been actively supporting
the NHP industry for over a decade through applied research activities
including product development, establishment of quality standards and
regulatory compliance. By providing fundamental investigations on
product quality, safety and efficacy, BCIT supports industry through
the entire continuum, from grower to manufacturer, ensuring product
integrity is maintained. Dr. Brown has spoken at numerous conferences
over the last decade on product quality standards, analytical method
validation and is currently Chair of NSF's Dietary Supplement Joint
Committee. Dr. Brown sits on the advisory Board of the American
Botanical Council, is a Fellow of the AOAC International having served
as General Referee for the Dietary Supplement Methods Committee from
2004-2009, from 2008-2013 was "Quality Focus" columnist for
Nutraceuticals World, an Industry Trade Journal published by Rodman
Publishing. Dr. Brown has reviewed and contributed to several American
Herbal Pharmacopeia Monographs including Black Cohosh and Ginseng.
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. is a specialty biotechnology company with
capabilities through its wholly owned subsidiaries of producing,
licensing and marketing proprietary ingredients and products containing
standardized phytochemicals for sale in Pharmaceutical, Nutraceutical,
Cosmetic and Animal Nutrition markets. The company also has a deep
pipeline of proprietary products ready for sale in high growth areas of
Functional Foods and Supplements business. For more information, visit
the Company's website at www.abattis.com.
ON BEHALF OF THE BOARD
Michael Withrow, President & CEO
Neither the CNSX Exchange nor its regulations services accepts
for the adequacy or accuracy of this release.
SOURCE: Abattis Bioceuticals Corp.
For further information: